Table 1 Comparison between included cases of leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) regarding clinicopathological features
Characteristics | All (N = 44) | LMS (N = 22) | ESS (N = 22) |
|---|---|---|---|
No. (%) | No. (%) | No. (%) | |
Age (years) | |||
 Mean ± SD | 56.84 ±7.93 | 62.50 ±4.94 | 51.18 ±6.10 |
 Median (Range) | 57 (39-72) | 62 (56-72) | 50 (39-65) |
 ≤ 55 years | 18 (40.9%) | 0 (0%) | 18 (81.8%) |
 > 55 years | 26 (59.1%) | 22 (100%) | 4 (18.2%) |
Size | |||
 <5 cm | 6 (13.6%) | 4 (18.2%) | 2 (9.1%) |
 >5 cm | 38 (86.4%) | 18 (81.8%) | 20 (90.9%) |
Grade | |||
 Grade I | 9 (20.5%) | 5 (22.7%) | 4 (18.2%) |
 Grade II | 12 (27.3%) | 7 (31.8%) | 5 (22.7%) |
 Grade III | 23 (52.3%) | 10 (45.5%) | 13 (59.1%) |
Extrauterine extension | |||
 Absent | 6 (13.6%) | 4 (18.2%) | 2 (9.1%) |
 Present | 9 (20.5%) | 5 (22.7%) | 4 (18.2%) |
 N/A | 29 (65.9%) | 13 (59.1%) | 16 (72.7%) |
LVSI | |||
 Absent | 21 (47.7%) | 14 (63.6%) | 7 (31.8%) |
 Present | 23 (52.3%) | 8 (36.4%) | 15 (68.2%) |
Bladder/Rectum extension | |||
 Absent | 33 (75%) | 18 (81.8%) | 15 (68.2%) |
 Present | 10 (22.7%) | 4 (18.2%) | 6 (27.3%) |
 N/A | 1 (2.3%) | 0 (0%) | 1 (4.5%) |
Other pelvic organ invasion | |||
 Absent | 15 (34.1%) | 8 (36.4%) | 7 (31.8%) |
 Present | 29 (65.9%) | 14 (63.6%) | 15 (68.2%) |
Adnexal invasion | |||
 Absent | 11 (25%) | 7 (31.8%) | 4 (18.2%) |
 Present | 33 (75%) | 15 (68.2%) | 18 (81.8%) |
Lymph node | |||
 Negative | 16 (36.4%) | 10 (45.5%) | 6 (27.3%) |
 Positive | 28 (63.6%) | 12 (54.5%) | 16 (72.7%) |
Distant metastasis | |||
 Absent | 29 (65.9%) | 18 (81.8%) | 11 (50%) |
 Present | 15 (34.1%) | 4 (18.2%) | 11 (50%) |